Piper Jaffray has raised the price target on Watson Pharmaceuticals (NYSE:
WPI) from $72 to $76 and maintains its Overweight rating.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
